Order results by:
| Issue | Title | |
| Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
| P. N. Vlasov | ||
| "... . The emergence of a new sustained-release levetiracetam formulation in neurologists' practice greatly enhances ..." | ||
| Vol 4, No 1 (2012) | Generalized epilepsies: current conceptions and therapeutic approaches | Abstract similar documents |
| L R Zenkov | ||
| "... , dosage form, side effects, and cost. Among broad-spectrum agents (valproate (VPA), levetiracetam ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | New antiepileptic drugs, cost-efficacy analysis | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, T. I. Konovalova | ||
| "... and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Long-term levetiracetam monotherapy for partial epilepsy in adults | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, E. G. Komelkova, Z. S. Shakhabasova | ||
| "... The paper analyzes the efficiency of 3-year monotherapy with levetiracetam (LTC) (keppra) in 143 ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova | ||
| "... Objective: to analyze the efficacy and tolerability of sustained-release sodium valproate (SV ..." | ||
| Vol 11, No 4 (2019) | Genetic risk factors for behavioral adverse reactions in epileptic patients taking levetiracetam | Abstract similar documents |
| A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder | ||
| "... Levetiracetam (LEV) is an effective antiepileptic drug. Nevertheless, when the drug is used, its ..." | ||
| Online-first | GENETIC RISK FACTORS FOR THE DEVELOPMENT OF BEHAVIORAL ADVERSE DRUG REACTIONS IN PATIENTS WITH EPILEPSY TAKING LEVETIRACETAM | Abstract similar documents |
| A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder | ||
| "... Levetiracetam (LEV) is a highly effective antiepileptic drug (AED). However, unwanted behavioral ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... Objective: to evaluate the efficacy and tolerability of levetiracetam (LEV) (epiterra, TEVA ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... with levetiracetam (LEV), a brand-name drug (bLEV; Keppra, UCB Pharma, Belgium) and its generic (gLEV; Epiterra ..." | ||
| No 1S (2016): | Status epilepticus: Analysis of refractory cases | Abstract similar documents |
| B. P. Gladov, O. A. Podgornaya, P. N. Vlasov | ||
| "... antiepileptic drugs (AEDs), such as diazepam (DZP); valproic acid (VPA); levetiracetam; and lacosamide ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | The Clinical and Neurophysiological Features of Epileptic Syndromes Associated with Benign Focal Epileptiform Discharges of Childhood | Abstract similar documents |
| N. A. Ermolaenko, I. A. Buchneva, E. I. Zakharova | ||
| "... % even if they have no epileptic seizures. Duo-therapy with valproate and ethosuximide or levetiracetam ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Intravenous Antiepileptic Drugs in Russia | Abstract similar documents |
| P. N. Vlasov | ||
| "... (Vimpat), and levetiracetam (Keppra) – into the Russian market has significantly broadened ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... increases the adherence of a patient with PD to regular treatment. Two (extended- and immediate-release ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... Extended-release ropinirole is a new formulation of the well-known nonergolinic D2/D3 dopamine ..." | ||
| Vol 8, No 2 (2016) | Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over | Abstract similar documents |
| G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova | ||
| "... Objective: to evaluate the efficacy of prolonged-release melatonin used in routine practice ..." | ||
| Vol 2, No 3 (2010) | Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy | Abstract similar documents |
| E. D. Belousova | ||
| "... Objective: to evaluate the efficacy and tolerability of sustained-release sodium valproate sodium ..." | ||
| Vol 15, No 4 (2023) | Evaluation of pharmacokinetic parameters, safety and tolerability of single and multiple doses of Vespireit®: results of phase I clinical trial. | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, M. V. Zamergrad, V. A. Parfenov, E. K. Zaharova, A. L. Vladykin, A. A. Globenko, A. V. Kapashin, K. A. Ishchenko | ||
| "... buspirone), prolonged-release tablets, 15 mg (JSC “Valenta Pharm”, Russia), which is being developed ..." | ||
| Vol 2, No 2 (2010) | Antiaggregant therapy in neurological practice: objectives and possibilities | Abstract similar documents |
| E. V. Portnyagina, A. F. Portnyagin | ||
| Vol 15, No 5 (2023) | Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, A. S. Agafina, N. V. Lyamina, M. M. Gavrik, L. R. Kuchumova, E. R. Barantsevich, V. S. Krasnov, A. A. Ivanova, A. L. Vladykin, K. А. Ishchenko | ||
| "... : to evaluate the efficacy and safety of Vespireit® (INN buspirone) prolonged-release tablets 15 mg2 (JSC ..." | ||
| Vol 13, No 6 (2021) | Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain | Abstract similar documents |
| V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya | ||
| "... Prolonged release tolperisone hydrochloride 450 mg (PRTH 450) is a dosage form that is convenient ..." | ||
| Vol 12, No 2 (2020) | The history of mianserin and mirtazapine: study of their neurochemical activity and determination of their position in the classification of antidepressants | Abstract similar documents |
| D. S. Danilov, Yu. G. Tyulpin, V. D. Morozova | ||
| "... the release of norepinephrine into the synaptic cleft, is shown to have gained unanimously acceptance ..." | ||
| Vol 15, No 3 (2023) | Cefepime-induced encephalopathy | Abstract similar documents |
| T. N. Pushkar, P. N. Vlasov, A. I. Belyakova-Bodina, A. G. Broutian | ||
| "... with intravenous administration of an antiepileptic drug (levetiracetam) was negative. A day after the withdrawal ..." | ||
| Vol 12, No 1 (2020) | Gender characteristics of therapy for genetic generalized epilepsy in adults | Abstract similar documents |
| I. V. Volkov, G. S. Karpovich, A. V. Kalina, O. K. Volkova | ||
| "... syndromes. Most patients received valproates; more than 35% took levetiracetam; lamotrigine was used ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Epilepsy and autism: The authors’ study data | Abstract similar documents |
| K. V. Voronkova, O. A. Pylayeva, A. A. Kholin, G. S. Golosnaya, T. V. Ananyeva, A. S. Petrukhin | ||
| "... of therapy in the children followed up. Levetiracetam, etosuximide, and other antiepileptic medications were ..." | ||
| Vol 7, No 3 (2015) | Experience with sustained-release melatonin for the treatment of sleep disorders in depression | Abstract similar documents |
| Svetlana Vladimirovna Prokhorova, T. N. Maksimova | ||
| "... . Sustained-release melatonin is a synthetic analogue of the endogenous human pineal hormone melatonin ..." | ||
| Vol 5, No 2 (2013) | Locomotor therapy with extended-release crystalline glucocorticoids | Abstract similar documents |
| Vladimir Vasilyevich Badokin | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... . A novel extended-release formulation of pramipexole is considered separately. Both immediate- and extended ..." | ||
| Vol 4, No 2 (2012) | Therapy for back pain syndrome | Abstract similar documents |
| E Yu Solovyeva | ||
| "... -release enteric-coated granules and individual immediate-release granules of vitamins B 1 ..." | ||
| Vol 4, No 2 (2012) | Impact of antiepileptic therapy on the course of affective disorders in women with epilepsy | Abstract similar documents |
| E V Zheleznova, I L Medvedev, V V Kalinin | ||
| "... Проведен анализ влияния противоэпилептических препаратов (ПЭП) на аффективные расстройства у женщин ..." | ||
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... dyskinesias. Controlled-release DRAs are of particular interest. The results of using requip modutab in PD ..." | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... The prolonged release tablets form of alimemazine is seen as a promising agent for the long-term ..." | ||
| No 1S (2016): | Molecular mechanisms responsible for the impact of antiepileptic therapy on bone mineral density of epileptic patients | Abstract similar documents |
| I. A. Zhidkova, T. V. Kaznacheeva, E. Yu. Demidova, V. V. Berseneva | ||
| "... Противоэпилептические препараты (ПЭП) могут оказывать неблагоприятное влияние на костную ткань ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Rationale for mono- versus polytherapy with antiepileptic drugs for patients with epilepsy | Abstract similar documents |
| L. V. Lipatova, T. V. Kapustina | ||
| "... после неудачи монотерапии первым противоэпилептическим препаратом (ПЭП). При выборе альтернативной ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Russian Register of Pregnancy and Epilepsy | Abstract similar documents |
| D. V. Dmitrenko, N. A. Schnaider, A. N. Goroshkin, A. I. Tomilina, P. N. Vlasov, M. R. Sapronova | ||
| "... Применение противоэпилептических препаратов (ПЭП) во время беременности связано с повышенным ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Efficiency and tolerance of sustained-release valproate sodium (Depakine®ChronosphereТМ) as the drug of the first choice in the treatment of adult epilepsy | Abstract similar documents |
| E. D. Belousova, G. N. Avakyan | ||
| Vol 4, No 2 (2012) | Sleep and memory problems: acetylcholine in some neurodegenerative diseases, use of an extended-release formulation of galantamine | Abstract similar documents |
| I V Litvinenko | ||
| Vol 14, No 3 (2022) | Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke | Abstract similar documents |
| M. Yu. Maksimova, A. S. Airapetova | ||
| "... of clopidogrel and ASA, and the combination of ASA with sustained release dipyridamole have been shown ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... release formulation: the administration of the drug considerably reduces the dose titration period ..." | ||
| Vol 15, No 4 (2023) | Pharmacokinetic parameters, safety and drug-drug interactions of mirtazapine and tizanidine, combined in the new original drug Dorsumio® | Abstract similar documents |
| A. S. Goncharov, A. V. Grigoriev, A. A. Globenko, I. S. Goncharov, K. A. Muratov, D. V. Yaroshenko, A. A. Sidorova, A. V. Kapashin, O. V. Kovchan, A. I. Bashkatova, M. A. Pasko | ||
| "... + tizanidine, extended-release tablets, 15 mg + 6 mg, JSC Valenta Pharm, Russia) taken once by healthy ..." | ||
| Vol 13, No 6 (2021) | Post-release of the symposium «How to Deal with Pain in the 21st Century? Expert Opinions» (November 8, 2021, XII Interdisciplinary International Congress «Manage Pain») | Abstract similar documents |
| T. M. Ostroumova | ||
| Vol 1, No 3-4 (2009) | RUSSIAN OBSERVATIONAL SURVEY OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF SUSTAINED-RELEASE SODIUM VALPROATE (DEPAKINE CHRONOSPHERA®) AS A FIRST-LINE DRUG IN THE TREATMENT OF EPILEPSY | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... Objective. To have additional data on the short-term safety and efficacy of sustained-release ..." | ||
| Vol 7, No 3 (2015) | Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision | Abstract similar documents |
| Irina Gennadyevna Rudakova, Yu. A. Belova | ||
| "... противоэпилептических препаратов (ПЭП) в соответствии с их международным непатентованным наименованием. Пациенты и ..." | ||
| Vol 9, No 2 (2017) | Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova | ||
| "... acetylcholine release to a large extent than benfotiamine. These molecular effects are consistent ..." | ||
| Vol 12, No 6 (2020) | The use of perampanel in drug-resistant focal epilepsy: its effect on sleep | Abstract similar documents |
| A. A. Filin, M. V. Tardov, N. L. Kunelskaya, P. N. Vlasov | ||
| "... Перампанел (ПЕР) – противоэпилептический препарат (ПЭП), исследований влияния которого на сон в ..." | ||
| Vol 16, No 4 (2024) | Functional dizziness: from diagnostic criteria to clinical profiles and therapy. Expert consensus | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, O. D. Ostroumova, A. L. Guseva, O. V. Zaytseva, Yu. P. Sivolap, I. V. Kukes, V. A. Voronov | ||
| "... psychotherapy and vestibular rehabilitation methods. The use of buspirone prolonged-release tablets (Vespirate ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of hormone-dependent pathology in female patients with juvenile myoclonic epilepsy | Abstract similar documents |
| D. V. Anisimova, R. V. Magzhanov, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova | ||
| "... препараты (ПЭП) на протяжении года и более в режиме моно- и битерапии. Результаты. У 66,7% пациенток ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Hormone-dependent abnormality of the female sexual sphere during monotherapy with valproate, carbamazepine, and lamotrigine | Abstract similar documents |
| P. N. Vlasov, O. F. Serova, D. V. Dranko, N. V. Filatova, Z. S. Shakhabasova | ||
| "... лет), получавших монотерапию противоэпилептическими препаратами (ПЭП) не менее года. 40 из этих ..." | ||
| Vol 12, No 3 (2020) | Drug-induced cognitive impairment | Abstract similar documents |
| O. D. Ostroumova, M. I. Kulikova, T. M. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, V. A. Parfenov | ||
| "... . The treatment of this CI involves primarily dose withdrawal or reduction and the use of sustained-release dosage ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | Unverricht-Lundborg disease in an adult female patient: a clinical case | Abstract similar documents |
| V. A. Karlov, I. A. Zhidkova, E. Yu. Mishina, P. N. Vlasov, N. V. Margosyuk, L. P. Tingaeva, E. M. Perepelova, V. A. Perepelov, B. P. Gladov, S. A. Trukhanov | ||
| "... contribution to the achievement of certain success of currently available antiepileptic drugs, levetiracetam ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | The effect of antiepileptic drugs on cognitive functions | Abstract similar documents |
| A. S. Kotov | ||
| "... , valproates, oxcarbazepine, topiramate, lamotrigine, and levetiracetam in terms of their action ..." | ||
| Vol 2, No 4 (2010) | Gastrointestinal events during treatment with nonsteroidal anti-inflammatory drugs (according to the data of the CONDOR study) | Abstract similar documents |
| V. V. Alekseev | ||
| "... receiving celecoxib in a dose of 200 mg twice daily or sustained-release diclofenac 75 mg twice daily ..." | ||
| Vol 3, No 2 (2011) | The hemostatic system in neonates whose mothers took antiepileptic agents during pregnancy | Abstract similar documents |
| V. A. Petrukhin, V. L. Grishin, A. P. Mel'nikov, P. N. Vlasov, G. R. Drozhzhina | ||
| "... препараты (ПЭП). Пациенты и методы. Проведено наблюдение за 187 новорожденными. Среди препаратов, которые ..." | ||
| Vol 12, No 3 (2020) | The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index | Abstract PDF (Eng) similar documents |
| V. A. Karlov, P. N. Vlasov, A. B. Kozhokaru, A. S. Samoilov, A. S. Orlova | ||
| "... Лакосамид (ЛКМ) — один из наиболее перспективных противоэпилептических препаратов (ПЭП) при ..." | ||
| No 1S (2016): | The pattern of female genital hormonal disease in juvenile myoclonic epilepsy | Abstract similar documents |
| D. V. Anisimova, R. V. Magzhanov, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsevadze, S. R. Nurmukhametova, F. Yu. Garifullina | ||
| "... противоэпилептические препараты (ПЭП) на протяжении более года в режиме монои битерапии. Для сравнения показателей в ..." | ||
| Vol 2, No 2 (2010) | Neuropathology of epileptic encephalopathies and non-paroxysmal epileptic disorders and principles of their treatment | Abstract similar documents |
| L. R. Zenkov | ||
| "... epileptiform activity (valproate, levetiracetam, and lamotrigine) as a first-choice drug and caution when ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Cognitive and emotional changes in patients with juvenile myoclonic epilepsy | Abstract similar documents |
| R. V. Magzhanov, D. V. Anisimova, P. N. Vlasov, V. A. Petrukhin, E. B. Tsevtsivadze, S. R. Nurmukhametova | ||
| "... фона, принимаемых противоэпилептических препаратов (ПЭП) и течения заболевания в генезе выявленных ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | Additional sanogenetic effect of topiramate in the treatment of epilepsy in women of childbearing age | Abstract similar documents |
| N. V. Filatova, N. V. Orekhova, P. N. Vlasov | ||
| "... (ПЭП) с менструальным циклом, избыточной массой тела и репродуктивными расстройствами у женщин. В связи ..." | ||
| Vol 16, No 3 (2024) | Observational study of the effect of perampanel on sleep and daytime sleepiness in adult patients with epilepsy in real-life clinical practice | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, M. A. Vagina, A. V. Vasilenko, T. M. Goguadze, T. V. Danilova, O. N. Kirillovskikh, I. Yu. Kovaleva, Yu. A. Kornukova, S. Yu. Lavrik, I. V. Larina, L. V. Lipatova, E. R. Tokareva, A. V. Ulitin, N. V. Filatova, M. A. Yamin | ||
| "... дополнительного противоэпилептического препарата (ПЭП) в терапии эпилепсии у взрослых. Материал и методы. В ..." | ||
| Vol 7, No 3 (2015) | Therapy for epilepsy in women: Additional sanogenetic effect caused by the intake of topiramate | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, N. V. Filatova | ||
| "... , преимущественно получавших комбинированную терапию 2 противоэпилептическими препаратами (ПЭП). У 82,8% пациенток ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Mechanisms of valproate-induced teratogenesis | Abstract similar documents |
| D. V. Dmitrenko, N. A. Shnaider, I. G. Strotskaya, A. S. Kichkaylo, S. N. Zobova | ||
| "... Риски, связанные с внутриутробным влиянием противоэпилептических препаратов (ПЭП), имеют большое ..." | ||
| Vol 13, No 3 (2021) | Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults | Abstract similar documents |
| T. N. Pushkar, A. M. Azhigova, P. N. Vlasov, A. B. Kozhokaru | ||
| "... Окскарбазепин (ОКС) – противоэпилептический препарат (ПЭП), используемый у детей и у взрослых ..." | ||
| Vol 13, No 4 (2021) | Pharmacodynamic sodium channel blockers-induced seizure aggravation in patients with newly diagnosed focal epilepsy | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, A. M. Azhigova, A. B. Kozhokaru, A. S. Orlova | ||
| "... эпилепсии) назначения противоэпилептического препарата (ПЭП). Многие механизмы его развития и возможности ..." | ||
| Vol 5, No 1S (2013): Special issue "Epilepsy" | Effect of drug formulation on the treatment of epilepsy | Abstract similar documents |
| S. G. Burd | ||
| "... on therapy efficiency, safety, and compliance in epileptic patients. Switching from sustained-release ..." | ||
| Vol 4, No 2 (2012) | Artra is a model of combination symptom-modifying therapy for osteoarthrosis and intervertebral osteochondrosis | Abstract similar documents |
| V V Badokin | ||
| "... The paper gives an update on therapy for osteoarthrosis (OA). Symptomatic sustained-release drugs ..." | ||
| Vol 12, No 6 (2020) | Use of akatinol memantine for the treatment of Korsakoff's syndrome: a clinical case | Abstract similar documents |
| N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova, V. O. Vysokova | ||
| "... высвобождение которого из связи с NMDA-рецепторами происходит в период отмены этанола. В последнее время для ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... the new prolonged release formulation Betaserc® Long), glucocorticoids, and gentamicin for Meniere ..." | ||
| Vol 10, No 4 (2018) | Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner) | Abstract similar documents |
| P. N. Vlasov | ||
| "... -release formulations of VA and CBZ remain the drugs of first choice for many types of epilepsy. CBZ ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Use of valproates in women of childbearing age and pregnant women with epilepsy | Abstract similar documents |
| P. N. Vlasov | ||
| "... effective daily dose and sustained-release formulations. ..." | ||
| Vol 14, No 6 (2022) | Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice | Abstract similar documents |
| R. K. Shikhkerimov, E. V. Istomina | ||
| "... -sensitive factor [NSF] Attachment Protein Receptor), as a result of which the release of acetylcholine ..." | ||
| No 1S (2016): | Clinical and electroencephalographic characteristics of chronic tic disorders in children and adolescents | Abstract similar documents |
| N. A. Ermolenko, E. I. Zakharova, I. A. Buchneva | ||
| "... with antiepileptic drugs (extended-release valproic acid) was effective and safe in both epileptic seizures ..." | ||
| 1 - 70 of 70 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
